24/7 Customer Support

+1 718 473 0872

Generic Drug Industry

Biosimilars and their Contribution to Increasing Patient Access to Essential Medicines

  • May 2011
  • 20 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

  • Segment Coverage

    Generic Drug  

    Biosimilars  

  • Geographic Coverage

    Europe  

    Germany  

    United States  

    United Kingdom  

  • Biosimilars and their contribution to increasing patient access to essential
  • medicines 1
  • Basel, May 20, 2011 1
  • At Sandoz/Novartis, innovative and follow-on biologics are developed and
  • manufactured in the same cutting edge facilities 2
  • Biosimilars are systematically developed to match the molecular attributes of
  • the reference product 3
  • Variability is significant in original biological products 4
  • Growing demand drives costs... and threatens to limit patient access (US
  • example) 5
  • $63 billion in global biologics sales will be off patent by 2016 7
  • Europe: German example shows immediate savings from biosimilars - and huge
  • potential 8
  • UK example: Biosimilars expand access to GCSF 9
  • Genuine competition - with a ?level playing field? for all biologics - will lead
  • to increased innovation 11
  • Backup slides 12
  • Pharmacovigilance and naming 13
  • Biologics are more complex than small molecules... 15
  • Biosimilars are recognized around the world as safe and effective medicines 16
  • Biosimilars development requires substantive investment and time 17
  • Sandoz is the world leader in developing, manufacturing and commercializing
  • biosimilars 18
  • Unique position within Novartis provides powerful and entrenched - competitive
  • advantage 19
  • Sandoz biosimilars: #1 with 3 marketed products 20
  • Estimated daily treatment costs 5
  • By 2016, 7 of the top 10 pharmaceuticals worldwide will be biologics, driving up
  • healthcare costs 6
  • WW Biologics sales 7
  • EPO market in Germany: Effect of biosimilar market entry, 8
  • UK G-CSF volume growth 9
  • Sandoz drove leading market share for Zarzio in Sweden while increasing patient
  • access 10
  • What is a biosimilar (or follow-on biologic)? 14

Refine your search results

Additional Related Reports

Biosimilars Market Share in Europe - Forecast

  • Executive Summary
  • January 2014
    2 pages
  • Biosimilars  

  • Spain  

    Europe  

    Germany  

View report >

Drug Industry

  • Lessons for Follow-on Biologics from Small Molecule Drugs
  • February 2014
    16 pages
  • Drug  

View report >

Global Generic Drug Market Forecast

  • Global Market for Generic Drugs to Reach $129 Billion in 2014
  • January 2014
    2 pages
  • Generic Drug  

    Generic Drugs  

    Generics  

  • World  

    Europe  

    India  

View report >

Generic Drug Industry

8 months ago

Purchase Reports From Reputable Market Research Publishers

Analyzing the Global Generics Industry 2014

Analyzing the Global Generics Industry 2014

  • $ 1 750
  • Industry report
  • August 2014
  • by Aruvian's R'search

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global ...

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

  • $ 495
  • Industry report
  • April 2014
  • by MarketLine

Introduction In October 2013, Teva announced that it would be cutting approximately 10% of the workforce in order to cut costs. Later that month, it announced the departure of its CEO of just 18 months, ...

Global Generic Drugs Market 2014-2018

Global Generic Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Global Hyaluronic Market 2012-2016

October 2013 $ 2 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.